Home' Australian Pharmacist : Australian Pharmacist September 2016 Contents Australian Pharmacist September 2016 I ©Pharmaceutical Society of Australia Ltd.
CONTINUING PROFESSIONAL DEVELOPMENT
1. Regarding gastro-oesophageal reflux
disease (GORD) and the link to a cough,
which of the following is CORRECT?
a) Patients with GORD will always
experience a cough.
b) In most cases, it is easy to diagnose
GORD as the cause of a cough.
c) Common symptoms of GORD are
heartburn, acid regurgitation and a
d) In some cases, patients with GORD may
have a cough, but not experience reflux
2. Which of the following is INCORRECT?
a) Post-viral coughs can occur for up to
8 weeks after a viral infection.
b) The production of excess mucus in cigarette
smokers can lead to a ‘smoker’s cough’.
c) Patients with allergic rhinitis can
experience a cough associated with
d) Cough associated with post-nasal drip is
usually worse during the afternoon.
3. Angiotensin-converting enzyme
(ACE) inhibitors can cause a cough.
Which of the following is CORRECT?
a) Coughs associated with an ACE inhibitor
are usually chesty.
b) ACE inhibitor coughs are dose-
dependent in nature.
c) Around 20% of patients taking an ACE
inhibitor may experience a cough.
d) ACE inhibitor coughs always start within
hours of treatment initiation.
4. With regards to the management of
an ACE inhibitor cough, which of the
following is CORRECT?
a) The ideal option is to cease therapy
with an ACE inhibitor in cases of an
b) Patients who have experienced an
ACE inhibitor cough should not be
re-challenged with an ACE inhibitor.
c) An ACE inhibitor-induced cough is easily
treated with standard cough remedies.
d) Patients who experience an ACE
inhibitor cough should not be
prescribed an angiotensin ll type I
1. Meneghetti A. Upper respiratory tract infection clinical
presentation. In: Medscape. 2016. At: http://emedicine.
2. Mayo Clinic. Chronic cough. 2016. At: www.mayoclinic.org/
3. US Department of Health and Human Services. Centers
for Disease Control and Prevention . Pertussis (whooping
cough). 2016. At: www.cdc.gov/pertussis/about/index.
4. MyDr. Cough: dry cough. 2016. At: www.mydr.com.au/
5. National Asthma Council Australia. Allergic rhinitis (hay
fever) and your asthma. 2012. At: www.nationalasthma.org.
6. Australasian Society of Clinical Immunology and Allergy.
Information for patients, consumers and carers: Is it allergic
rhinitis (hay fever)? 2015. At: www.allergy.org.au/patients/
7. Australian Government. Cancer Australia. Lung cancer.
2016 At: https://lung-cancer.canceraustralia.gov.au
8. American Cancer Society. Signs and symptoms
of lung cancer. 2016. At: www.cancer.org/cancer/
9. American Academy of Allergy Asthma and Immunology.
Asthma. 2016. At: www.aaaai.org/conditions-and-
10. NHS Choices. Asthma – symptoms. 2014. At: www.nhs.uk/
11. Joffe D, Smith GS, Stiel D. Pulmonary manifestations of
gastro-oesophageal reflux disease. Australian Doctor
12. Madanick R. Management of GERD-related chronic cough.
Gastroenterol Hepatol (N Y) 2013;9(5):311–13.
13. US Department of Health and Human Services. Centers for
Disease Control and Prevention. Health effects of cigarette
smoking. 2016. At: www.cdc.gov/tobacco/data_statistics/
14. Quit Victoria. What are the effects of smoking on the
lungs? 2016. At: www.quit.org.au/about/frequently-asked-
15. Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-
induced cough: ACCP evidence-based clinical practice
guidelines. Chest 2006;129(1 Suppl):169S–73S.
16. Dykewicz M. Cough and angioedema from angiotensin-
converting enz yme inhibitors: new insights into
mechanisms and management. Curr Opin Allergy
Clin Immunol 2004;4(4). At: www.medscape.com/
17. Rossi S, ed. Australian medicines handbook. Adelaide:
Australian Medicines Handbook; 2016. At: http://
18. Caldeira D, David C, Sampaio C. Tolerability of angiotensin-
receptor blockers in patients with intolerance to
angiotensin-converting enzyme inhibitors: a systematic
review and meta-analysis. Am J Cardiovasc Drugs
KEY LEARNING POINTS
Persistent (or chronic) coughs can
have a variety of causes. In some cases,
a persistent cough may be linked to
a serious underlying pathology, such
as lung cancer or asthma. Hence, it is
important that the pharmacist takes
a detailed patient history, including
details of other symptoms occurring
at the same time as the cough.
This will allow for a differential
ACE inhibitor coughs are fairly
common, occurring in around 20% of
patients taking these agents. The best
course of action, in cases of an ACE
inhibitor cough, is to cease therapy,
which usually leads to symptom relief
within 4 weeks. However, in some
cases, the cough persists for up to
Links Archive Australian Pharmacist August 2016 Australian Pharmacist October 2016 Navigation Previous Page Next Page